Xianyi Sha

6.2k total citations · 1 hit paper
98 papers, 5.3k citations indexed

About

Xianyi Sha is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Xianyi Sha has authored 98 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 38 papers in Biomaterials and 30 papers in Biomedical Engineering. Recurrent topics in Xianyi Sha's work include Nanoparticle-Based Drug Delivery (38 papers), Nanoplatforms for cancer theranostics (28 papers) and RNA Interference and Gene Delivery (13 papers). Xianyi Sha is often cited by papers focused on Nanoparticle-Based Drug Delivery (38 papers), Nanoplatforms for cancer theranostics (28 papers) and RNA Interference and Gene Delivery (13 papers). Xianyi Sha collaborates with scholars based in China, United States and South Korea. Xianyi Sha's co-authors include Xiaoling Fang, Yanzuo Chen, Jijin Gu, Xinyi Jiang, Hongliang Xin, Liangcen Chen, Junguo Hao, Wei Zhang, Wuli Yang and Ye Jiang and has published in prestigious journals such as Advanced Materials, Neuron and Journal of Clinical Oncology.

In The Last Decade

Xianyi Sha

97 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-CHAC1 exosomes for nose-to-brain delivery of miR-760-3p in cerebral ischemia/reperfusion injury mice inhibiting neuron ferroptosis

2023 105 citations Xianyi Sha et al. Journal of Nanobiotechnology profile →

Peers

Countries citing papers authored by Xianyi Sha

Since Specialization

Citations

This map shows the geographic impact of Xianyi Sha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianyi Sha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianyi Sha more than expected).

Fields of papers citing papers by Xianyi Sha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianyi Sha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianyi Sha. The network helps show where Xianyi Sha may publish in the future.

Co-authorship network of co-authors of Xianyi Sha

This figure shows the co-authorship network connecting the top 25 collaborators of Xianyi Sha. A scholar is included among the top collaborators of Xianyi Sha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianyi Sha. Xianyi Sha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mitochondria-targeted manganese-based mesoporous silica nanoplatforms trigger cGAS-STING activation and sensitize anti PD-L1 therapy in triple-negative breast cancer 2025 ·Acta Biomaterialia ·Nan Zhong, Ziyue Zu, (unknown), Xianyi Sha, Yang Li, Yang Liu, S. Lu, Xi Luo, Yan Zhou, Junwu Tao, Feiyun Wu, (unknown), Yuxin Tang, Shouju Wang	4
2	Evaluation of Different Polysaccharide–Iron Complex Preparations In Vitro and In Vivo 2025 ·Pharmaceutics ·Xin Yan, Qi Zhang, Tao Wang, Yumei Luo, Xianyi Sha	0
3	Inhalable biomimetic polyunsaturated fatty acid-based nanoreactors for peroxynitrite-augmented ferroptosis potentiate radiotherapy in lung cancer 2025 ·Journal of Nanobiotechnology ·Yi-Ting Chen, Xueli Huang, Rong Hu, (unknown), (unknown), Xin Yan, Zhiwen Zhang, Yan Ma, (unknown), Xianyi Sha	2
4	Enhancement of cancer immunotherapy using CRT valgus tumor cell membranes coated bacterial whole peptidoglycan combined with radiotherapy 2023 ·International Journal of Pharmaceutics ·Xinhong Li, Yi‐Ting Chen, Rui Wang, (unknown), (unknown), Xianyi Sha	1
5	An In Vitro Comparative Study of Three Drug-Eluting Beads Loaded with Raltitrexed 2021 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown), Jun Tie, Lingxiao Liu, Dong Lu, (unknown), Xianyi Sha	3
6	<p>Pulmonary-Affinity Paclitaxel Polymer Micelles in Response to Biological Functions of Ambroxol Enhance Therapeutic Effect on Lung Cancer</p> 2020 ·International Journal of Nanomedicine ·Wenxiu He, (unknown), Xiulei Zhang, (unknown), (unknown), (unknown), Xiaoling Fang, (unknown), Xianyi Sha	19
7	<p>A carbohydrate mimetic peptide modified size-shrinkable micelle nanocluster for anti-tumor targeting and penetrating drug delivery</p> 2019 ·International Journal of Nanomedicine ·(unknown), Huihui Liang, (unknown), Yi‐Ting Chen, Wenxiu He, Xiaoling Fang, Xianyi Sha, Jinming Li	9
8	Matrix metalloproteinase 2/9-triggered-release micelles for inhaled drug delivery to treat lung cancer: preparation and in vitro/in vivo studies 2018 ·International Journal of Nanomedicine ·Xiaofei Wang, (unknown), Xiaoyan Zhang, Xiaoqing Ren, Xiulei Zhang, Lin Meng, Huihui Liang, Xianyi Sha, Xiaoling Fang	23
9	Complex Disease–, Gene–, and Drug–Drug Interactions: Impacts of Renal Function, CYP2D6 Phenotype, and OCT2 Activity on Veliparib Pharmacokinetics 2014 ·Clinical Cancer Research ·Jing Li, Seongho Kim, Xianyi Sha, Richard Wiegand, Jianmei Wu, Patricia LoRusso	30
10	In Vitro, Ex Vivo, and In Vivo Evaluation of the Effect of Saturated Fat Acid Chain Length on the Transdermal Behavior of Ibuprofen-Loaded Microemulsions 2014 ·Journal of Pharmaceutical Sciences ·(unknown), (unknown), (unknown), Rongjun Chen, (unknown), Xianyi Sha, (unknown)	26
11	Solid tumor penetration by integrin-mediated pegylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel 2012 ·Biomaterials ·Xinyi Jiang, Hongliang Xin, Jijin Gu, Ximing Xu, (unknown), Shuo Chen, Yike Xie, Liangcen Chen, Yanzuo Chen, Xianyi Sha, Xiaoling Fang	87
12	Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles 2012 ·Biomaterials ·Hongliang Xin, Xianyi Sha, Xinyi Jiang, Wei Zhang, Liangcen Chen, Xiaoling Fang	255
13	Transdermal microemulsion drug delivery system for impairing male reproductive toxicity and enhancing efficacy of Tripterygium Wilfordii Hook f 2012 ·Fitoterapia ·Xiao Wang, Mei Xue, Jijin Gu, Xiaoling Fang, Xianyi Sha	30
14	Enhanced anti-tumor effect of 9-nitro-camptothecin complexed by hydroxypropyl-β-cyclodextrin and safety evaluation 2011 ·International Journal of Pharmaceutics ·Ye Jiang, Xinyi Jiang, (unknown), Yanzuo Chen, Jijin Gu, Wei Zhang, Hongliang Xin, Xianyi Sha, Xiaoling Fang	40
15	The potential of Pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models 2011 ·Biomaterials ·Wei Zhang, Yuan Shi, Yanzuo Chen, Junguo Hao, Xianyi Sha, Xiaoling Fang	97
16	Complex of 9-nitro-camptothecin in hydroxypropyl-β-cyclodextrin: In vitro and in vivo evaluation 2010 ·International Journal of Pharmaceutics ·Ye Jiang, Xianyi Sha, Wei Zhang, Xiaoling Fang	19
17	Simultaneous determination of ABT-888, a poly (ADP-ribose) polymerase inhibitor, and its metabolite in human plasma by liquid chromatography/tandem mass spectrometry 2009 ·Journal of Chromatography B ·Richard Wiegand, Jianmei Wu, Xianyi Sha, Patricia LoRusso, Jing Li	21
18	Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate aminoflavone (NSC 686288) in human plasma 2009 ·Journal of Chromatography B ·Richard Wiegand, Jianmei Wu, Xianyi Sha, Patricia LoRusso, Elisabeth I. Heath, Jing Li	10
19	Oral Absorption of Ginsenoside Rb₁usingin vitroandin vivoModels 2006 ·Planta Medica ·Min Han, Xianyi Sha, (unknown), Xiaoling Fang	51
20	Transport characteristics of 9-nitrocamptothecin in the human intestinal cell line Caco-2 and everted gut sacs 2004 ·International Journal of Pharmaceutics ·Xianyi Sha, Xiaoling Fang	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact